COVIDIEN MFG DC BOULDER

Manufacturer adverse-event records for COVIDIEN MFG DC BOULDER come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2017–2025 · mid-book · typical Death-code · balanced

Injury-mix signature

COVIDIEN MFG DC BOULDER keeps a balanced Injury share

Injury-coded event_type share is 10.9% (balanced tercile) beside 0.58% Death-coded (typical). Volume band: mid.

What the Injury-mix reading shows for COVIDIEN MFG DC BOULDER

The standout signal for COVIDIEN MFG DC BOULDER is Injury-mix: 10.9% Injury-coded (balanced) beside 0.58% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for COVIDIEN MFG DC BOULDER. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Malfunction at 12,517 (88.5% of event_type total). Peak single-year volume reaches 2,274 reports across 9 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

14,148
Total Reports
82
Event-type Death
1,549
Injury Reports
20
Device Types

Event Types

Malfunction 12,517 (88.5%)
Injury 1,549 (10.9%)
Death 82 (0.6%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

12,334 (83.0%)
Required Intervention 738 (5.0%)
Other 719 (4.8%)
R 330 (2.2%)
Hospitalization 241 (1.6%)
O 187 (1.3%)
H 127 (0.9%)
Death 66 (0.4%)
L 45 (0.3%)
Life Threatening 42 (0.3%)
D 20 (0.1%)
S 3 (0.0%)
Disability 3 (0.0%)

Yearly Trend

17
2017: 1,390
18
2018: 1,684
19
2019: 1,684
20
2020: 1,553
21
2021: 1,697
22
2022: 1,578
23
2023: 1,603
24
2024: 2,274
25
2025: 685